IDEXX Laboratories Inc (IDXX)
Cash conversion cycle
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Days of inventory on hand (DOH) | days | 91.79 | 94.36 | 98.50 | 74.06 | 67.46 |
| Days of sales outstanding (DSO) | days | — | — | — | — | — |
| Number of days of payables | days | — | — | — | — | — |
| Cash conversion cycle | days | 91.79 | 94.36 | 98.50 | 74.06 | 67.46 |
December 31, 2024 calculation
Cash conversion cycle = DOH + DSO – Number of days of payables
= 91.79 + — – —
= 91.79
The cash conversion cycle of IDEXX Laboratories Inc has exhibited some fluctuations over the past five years. From December 31, 2020, where it stood at 67.46 days, the cycle increased to 74.06 days by December 31, 2021. Subsequently, there was a significant jump to 98.50 days by December 31, 2022, indicating a potential delay in converting inventory to cash.
However, there was a slight improvement by December 31, 2023, as the cycle decreased to 94.36 days. By December 31, 2024, the cash conversion cycle further reduced to 91.79 days, suggesting a positive trend in managing the company's cash conversion efficiency.
Overall, while there have been fluctuations, IDEXX Laboratories Inc appears to be taking steps to optimize its cash conversion cycle, with a focus on improving inventory turnover and working capital management.
Peer comparison
Dec 31, 2024